Developing antibody therapies to combat cancer and neurological diseases.
Industry: Health Care
First Day Return: -5.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/09/2018 |
Offer Price | $12.00 |
Price Range $12.00 - $15.00 | |
Offer Shares (mm) | 3.3 |
Deal Size ($mm) | $40 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 08/09/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $40 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Rochester, NY, United States |
Founded | 2001 |
Employees at IPO | 43 |
Website www.vaccinex.com |